


Searching News Database: Fumapharm
HSMN NewsFeed - 30 May 2006
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
Additional items found! 2
Members Archive contains
2 additional stories matching:
Fumapharm
(Password required)
Fumapharm
(Password required)
